Trademarkia Logo

Canada

C$
INTARCIA
REGISTERED

on 16 Dec 2019

Last Applicant/ Owned by

INTARCIA THERAPEUTICS INC.

One Marina Park Drive, Suite 1300Boston, Massachusetts 02210

US

Serial Number

1816220 filed on 29th Dec 2016

Registration Number

TMA1066451 registered on 16th Dec 2019

Registration expiry Date

16th Dec 2029

Correspondent Address

SMART & BIGGAR LP

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

INTARCIA

Trademark usage description

pharmaceutical hormonal preparations, namely, hormone analogues for the treatment of diabetes, obesity and metabolic diseases and disorders, namely, w Read More

Classification Information


Class [001]
Chemicals and adhesives


Comment text

CIPO Classification Code

Classification kind code

Nice

Class [005]
Pharmaceutical hormonal preparations, namely, hormone analogues for the treatment of diabetes, obesity and metabolic diseases and disorders, namely, weight loss, HIV and for the prevention of autoimmune diseases and disorders and anti-inflammatories; pharmaceutical preparations for the treatment of diabetes, obesity and metabolic diseases and disorders, namely, weight loss, HIV and for the prevention of autoimmune diseases and disorders and anti-inflammatories filled in drug delivery devices, namely implantable mini-pump drug delivery systems; pharmaceutical preparations for the treatment of diabetes, obesity and metabolic diseases and disorders, namely, weight loss, HIV and for the prevention of autoimmune diseases and disorders and anti-inflammatories; diagnostic preparations and reagents for clinical and medical laboratory use, all for in vivo use; medical apparatus in the nature of an implantable pump filled with pharmaceutical preparations and parts and fittings therefor for the treatment of diabetes, obesity and metabolic diseases and disorders, namely, weight loss, HIV and for the prevention of autoimmune diseases and disorders and anti-inflammatories.


Classification kind code

10

Class [010]
Drug delivery systems and devices, namely, implantable osmotic mini-pumps and parts and fittings therefor; implantable osmotic mini-pump drug delivery systems for the continuous release of a therapeutic formulation for the treatment of diabetes and parts and fittings therefor; medical apparatus for the administration of pharmaceuticals, biopharmaceuticals, vaccines and other therapeutic formulations in the nature of an implantable pump and parts and fittings therefor; medical apparatus and instruments for implanting and removing subdermal drug delivery devices in the nature of surgical preparation instruments and supplies, namely trays, needles, swabs, anesthetic preparations, alcohol prep pads, gloves, skin adhesive, needles, bandages, wound closure strips, syringe, scalpel, gauze, placement tool, hemostat, and removal tool and parts and fittings therefor; medical apparatus for treatment of diabetes, obesity and metabolic diseases and disorders, namely, malfunctioning condition of the body's metabolism process, in the nature of an implantable pump and parts and fittings therefor


Classification kind code

10

Class [042]
Providing scientific, pharmaceutical and medical research and development services in the fields of diabetes, obesity, metabolic diseases and disorders, drug delivery technologies, administration of pharmaceuticals, pharmaceuticals, and clinical trials; design and testing services in the fields of pharmaceuticals, biopharmaceuticals, science, namely, pharmacology and biology, medicine and drug delivery systems; research and development of new clinical products, drugs, pharmaceuticals and drug delivery systems and devices; computational and experimental research and development activities directed towards the identification and optimization of compounds and the development of drugs and drug delivery systems; information and advisory services in the field of pharmaceuticals, pharmacology and biology, medicine and drug delivery technologies, namely, the provision of information in the field of pharmaceuticals, pharmacology and biology and drug delivery technologies on-line from a computer network and via the Internet and extranets; Research and development of pharmaceutical preparations, products and technology in the fields of diabetes, obesity, metabolic diseases and disorders, namely, malfunctioning condition of the body's metabolism process, drug delivery technologies, and administration of pharmaceuticals; providing medical and scientific research information in the fields of diabetes, obesity, metabolic diseases and disorders, namely, malfunctioning condition of the body's metabolism process, drug delivery technologies, administration of pharmaceuticals, pharmaceuticals, and clinical trials; medical research; design and testing of new products, technologies and therapies in the fields of diabetes, obesity, metabolic diseases and disorders, namely, malfunctioning condition of the body's metabolism process, drug delivery technologies, and administration of pharmaceuticals.


Classification kind code

10

Mark Details


Serial Number

1816220

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 26
on 20th Jun 2019
Approved
Submitted for opposition 27
on 30th Apr 2019
Approval Notice Sent
Submitted for opposition 15
on 14th Jan 2019
Correspondence Created
Submitted for opposition 12
on 26th Apr 2018
Extension of Time
Submitted for opposition 135
on 19th Jan 2018
Amendment to Application
Submitted for opposition 22
on 4th Oct 2017
Search Recorded
Submitted for opposition 20
on 4th Oct 2017
Examiner's First Report
Submitted for opposition 31
on 4th Jan 2017
Formalized
Submitted for opposition 30
on 29th Dec 2016
Filed
Submitted for opposition 1
on 29th Dec 2016
Created